It’s Monday, and nutra has already thrown itself a little sale: somewhere payouts shot up, somewhere offers got delivered and hauled right back out. Classic — networks pretending everything’s under control while we’re busy counting who overpriced whom today.

🧪 Shakes has once again sprinkled the goodies over the Czechs and neighbors

Shakes gave Benaga Chaga and Cordyceps Pulse a batch reprice: in Czechia, Slovakia, Spain, Greece, Italy, Slovenia, Croatia, and Romania payouts jumped from 20–31.5 to 36–55. Nutra as usual: one minute it’s “we cure everything,” the next it’s suddenly a premium wellness product.

🎯 Benaga Chaga switched on the “let’s make it twice as expensive” mode

The single-country spikes were fun too: Benaga Chaga in Austria and Switzerland on vision went from 20 to 65 (+225%), in Hungary — to 42–40 (+100–110%), in Bulgaria — to 38 (+90%). In Germany, though, the party’s over: 65 → 52.5 (−19%). Even nutra occasionally remembers that greed is not a vitamin.

🫀 Cordyceps Pulse didn’t stay on the sidelines either

With Cordyceps Pulse in Belgium, the payout on prostatitis shot up from 20 to 50 (+150%), and in Spain on hemorrhoids treatment — 26 → 32.33 (+24%). Looks like the network decided: if we’re treating it, let’s make the buyer’s lower back twitch a little too, just from running the numbers.

🧾 Monolead CZ brought in a truckload of nutra and nearly cleared the shelves right away

In Czechia, Monolead dropped a whole pile of newbies: Arteolin for joints, Eronex for prostatitis, DM-Norm for diabetes, Farmacin, Fungizol, Metaglucin, RelioForm, NanoFlex, Prostas, Seropower, Toningem. And that was just so they could pull almost the entire set back down. Feels like that catalog runs on “launched it — changed our mind — deleted it.”

🧹 Pulls: the networks decided not to be polite

Among the noticeable removals were Parcel2Go UK from Admitad and Bodylab24 DE from the same network. And MetaCPA cleaned out InsuLevel in Italy, Virilift in Germany and Austria, Nemanex in France, and Erexol in Poland. For the networks, Monday came in with a very “if it’s cluttering up the place, out it goes” vibe.

📉 Targets are moving, but no fireworks yet

Among offer moves, REMONEX took the biggest hit: across Czechia, Spain, Greece, Croatia, Hungary, and Portugal it lost 8 targets. Uro Up Forte and Wellnexis in Austria and Germany are down −2, while Elesse Cream, Cholest Off, DiaFlex Forte, and a couple of hypertension pieces are down −1 each. On the plus side, VeinGuard in Bulgaria, plus Bold Pro plus and Horse Fire in India, gained +1 each. Not a meltdown, but the tail is definitely twitching a bit.